Anti-LGI1 Antibody Limbic Encephalitis Associated with Hepatocellular Carcinoma
暂无分享,去创建一个
[1] E. Sánchez,et al. Anti-LGI1 encephalitis , 2016, Neurology.
[2] M. Baulac,et al. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. , 2016, Brain : a journal of neurology.
[3] A. Vincent,et al. Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies , 2015, Neurotherapeutics.
[4] S. Irani,et al. Cell-surface central nervous system autoantibodies: Clinical relevance and emerging paradigms , 2014, Annals of neurology.
[5] B. Bettcher,et al. Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy. , 2014, JAMA neurology.
[6] Christian G Bien,et al. Autoantibodies associated with diseases of the CNS: new developments and future challenges , 2011, The Lancet Neurology.
[7] R. Balice-Gordon,et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series , 2010, The Lancet Neurology.
[8] A. Vincent,et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia , 2010, Brain : a journal of neurology.
[9] A. Larner,et al. An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[10] J. Oger,et al. Potassium channel antibodies in two patients with reversible limbic encephalitis , 2001, Annals of neurology.